DNA Damage and Repair

DNA damage is a constant threat to cellular integrity. Understanding how cells detect, repair, and respond to DNA damage is crucial for understanding cancer development and treatment.

Skeptic's corner: Not all DNA damage leads to cancer. The cell has multiple repair pathways, and many mutations are silent. The key is understanding which damage types are most dangerous and why repair fails.

---

Types of DNA Damage

Endogenous Damage (Internal)

• Reactive oxygen species (ROS): ~10,000 lesions per cell per day
• Replication errors: ~1 error per 10^9 bases
• Spontaneous hydrolysis: Depurination, deamination
• Metabolic byproducts: Formaldehyde, acetaldehyde

Exogenous Damage (External)

• UV radiation: Pyrimidine dimers, 6-4 photoproducts
• Ionizing radiation: Double-strand breaks, base damage
• Chemical mutagens: Alkylating agents, aromatic hydrocarbons
• Environmental toxins: Aflatoxin, benzene

---

DNA Repair Pathways

Base Excision Repair (BER)

• Targets: Single base damage, small lesions
• Key players: DNA glycosylases, AP endonuclease, DNA polymerase β
• Process:
  1. Glycosylase removes damaged base
  2. AP endonuclease cuts backbone
  3. DNA polymerase fills gap
  4. DNA ligase seals nick
• Cancer relevance: Defective in some cancers

Nucleotide Excision Repair (NER)

• Targets: Bulky lesions, UV damage
• Key players: XPA-XPG, TFIIH, XPC
• Process:
  1. Damage recognition
  2. Incision on both sides
  3. Removal of damaged strand
  4. Resynthesis and ligation
• Cancer relevance: Defective in xeroderma pigmentosum

Mismatch Repair (MMR)

• Targets: Base mismatches, insertion/deletion loops
• Key players: MSH2, MSH6, MLH1, PMS2
• Process:
  1. Mismatch recognition
  2. Strand discrimination
  3. Excision of incorrect strand
  4. Resynthesis and ligation
• Cancer relevance: Defective in Lynch syndrome

Homologous Recombination (HR)

• Targets: Double-strand breaks, stalled replication forks
• Key players: BRCA1, BRCA2, RAD51, PALB2
• Process:
  1. End resection
  2. Homology search
  3. Strand invasion
  4. DNA synthesis
  5. Resolution
• Cancer relevance: Defective in hereditary breast/ovarian cancer

Non-Homologous End Joining (NHEJ)

• Targets: Double-strand breaks
• Key players: Ku70/80, DNA-PKcs, XRCC4, Ligase IV
• Process:
  1. End recognition
  2. End processing
  3. Ligation
• Cancer relevance: Defective in some lymphomas

---

DNA Damage Response (DDR)

Sensors

• ATM: Responds to double-strand breaks
• ATR: Responds to replication stress
• DNA-PK: Responds to double-strand breaks
• PARP1: Responds to single-strand breaks

Transducers

• CHK1: ATR target, S-phase checkpoint
• CHK2: ATM target, G1/S checkpoint
• p53: Master regulator, apoptosis/senescence
• MDM2: p53 regulator

Effectors

• Cell cycle checkpoints: G1/S, S, G2/M
• DNA repair: Activation of repair pathways
• Apoptosis: p53-dependent cell death
• Senescence: Irreversible growth arrest

---

Laboratory Techniques

DNA Damage Detection

# γ-H2AX foci analysis
import matplotlib.pyplot as plt
import numpy as np
from scipy import ndimage

def analyze_gamma_h2ax(image):
    """
    Analyze γ-H2AX foci as markers of DNA damage
    """
    # Convert to grayscale
    gray = np.mean(image, axis=2)
    
    # Apply threshold
    threshold = np.percentile(gray, 95)
    binary = gray > threshold
    
    # Find connected components (foci)
    labeled, num_foci = ndimage.label(binary)
    
    # Calculate foci properties
    foci_props = []
    for i in range(1, num_foci + 1):
        foci_mask = labeled == i
        area = np.sum(foci_mask)
        intensity = np.mean(gray[foci_mask])
        foci_props.append({'area': area, 'intensity': intensity})
    
    return foci_props, num_foci

Repair Assays

• Comet assay: Single-cell DNA damage
• γ-H2AX: Double-strand break marker
• 53BP1 foci: DNA damage response
• RAD51 foci: Homologous recombination

---

Clinical Relevance

Hereditary Cancer Syndromes

Lynch Syndrome (HNPCC)

• Defect: MMR genes (MLH1, MSH2, MSH6, PMS2)
• Cancers: Colorectal, endometrial, ovarian
• Features: Microsatellite instability (MSI)

Hereditary Breast/Ovarian Cancer

• Defect: BRCA1, BRCA2
• Cancers: Breast, ovarian, prostate, pancreatic
• Features: Homologous recombination deficiency

Xeroderma Pigmentosum

• Defect: NER genes (XPA-XPG)
• Cancers: Skin cancers
• Features: UV sensitivity

Therapeutic Targets

PARP Inhibitors

• Mechanism: Synthetic lethality with HR defects
• Drugs: Olaparib, Rucaparib, Niraparib
• Indications: BRCA-mutant cancers

DNA Damage Response Inhibitors

• ATR inhibitors: Ceralasertib, Berzosertib
• CHK1 inhibitors: Prexasertib
• Status: Experimental

---

Research Applications

Biomarker Development

1. DNA damage markers: γ-H2AX, 53BP1
2. Repair deficiency: HRD score, MSI status
3. Therapeutic response: PARP inhibitor sensitivity

Drug Discovery

1. Target identification: DDR proteins
2. Synthetic lethality: PARP + HR defects
3. Combination therapy: DDR inhibitors + chemotherapy

---

Practical Considerations

Sample Preparation

• Fixation: Formalin-fixed paraffin-embedded (FFPE)
• Fresh tissue: Snap-frozen in liquid nitrogen
• Cell lines: Standard culture conditions

Data Analysis

• Foci counting: Automated image analysis
• Statistical analysis: Appropriate controls
• Reproducibility: Multiple replicates

---

FAQ

Q: Why do some DNA damage types cause cancer while others don't? A: It depends on the type of damage, where it occurs in the genome, and whether it's repaired correctly. Some damage types are more mutagenic than others.

Q: Can DNA repair be enhanced to prevent cancer? A: This is an active area of research, but enhancing repair without causing other problems is challenging.

Q: How do PARP inhibitors work? A: They trap PARP on DNA, creating lesions that require HR for repair. In HR-deficient cells, this leads to cell death.

---

References (APA Style)

Jackson, S. P., & Bartek, J. (2009). The DNA-damage response in human biology and disease. Nature, 461(7267), 1071-1078.

Lord, C. J., & Ashworth, A. (2012). The DNA damage response and cancer therapy. Nature, 481(7381), 287-294.

Roos, W. P., Thomas, A. D., & Kaina, B. (2016). DNA damage and the balance between survival and death in cancer biology. Nature Reviews Cancer, 16(1), 20-33.

---

Contributing

1. Review existing content for accuracy
2. Add missing repair pathways or damage types
3. Create practical examples and code snippets
4. Cite recent research and clinical trials

---

This article provides the foundation for understanding how DNA damage and repair mechanisms contribute to cancer development. Master these concepts to understand genomic instability and targeted therapies.